ISIS 104838, an Inhibitor of Tumor Necrosis Factor, for Active Rheumatoid Arthritis
Clinical trial NCT00048321 · COMPLETED
Trial details
- NCT number
- NCT00048321
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-01-01
- Primary completion
- 2003-02-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.